Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Taking out Nov lows today, news: Dec 8 (Reuters) - Six former Insys Therapeutics Inc executives and managers were arrested on Thursday on charges that they engaged in a nationwide scheme to bribe doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said. Michael Babich, the former CEO of the Arizona-based drug maker, was among five individuals charged in an indictment filed in federal court in Boston in the latest case to spill out of probes involving Insys' drug Subsys.
This is actually a good one to watch. Got to make sure the trouble get's behind them without dealing them a death blow. If they do, it could be a good one to try and ride back up.
great play on news - insiders still holding @ higher levels >> FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis https://finance.yahoo.com/news/fda-grants-insys-therapeutics-fast-100000549.html
You now that somebody got paid for that fast track from the FDA. What I would do to have access to that kind of info!
